Table 3.

Angina pectoris as a predictor of outcome on adjusted analysis.

End point	Adjusted* Hazard Ratio (95% Confidence Interval)	P-Value
Death/myocardial infarction/revascularization/stroke	1.30 (1.17–1.45)	<0.0001
Death/myocardial infarction/revascularization	1.29 (1.15–1.43)	<0.0001
Death/myocardial infarction/stroke	0.99 (0.87–1.11)	0.81
Death/myocardial infarction	0.93 (0.82–1.06)	0.27
Death	0.94 (0.82–1.06)	0.30
Cardiovascular death/cardiovascular hospitalization	0.95 (0.85–1.05)	0.32

^*Adjusted for age, ejection fraction, sex, race, hypertension, diabetes, prior myocardial infarction, hyperlipidemia, New York Heart Association class, cerebrovascular disease, peripheral vascular disease, previous smoking history, previous percutaneous coronary intervention, previous coronary artery bypass grafting, ventricular gallop, Charlson Index, body mass index, heart rate, systolic blood pressure, use of beta-blocker, ACE-inhibitor or angiotensin receptor blocker, hydralazine, nitrates, calcium channel blocker, aspirin, clopidogrel, statin, diuretic and serum creatinine, sodium, blood urea nitrogen and hemoglobin.